Endotronix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $600M

Endotronix General Information

Description

Developer of proactive heart management tools designed to detect cardiac failure. The company's tools offer a patient management platform and a pulmonary artery pressure sensor that connect patients, clinicians, and reimbursement teams through streamlined patient management, driving clinical and economic outcomes, enabling health professionals to help patients detect worsening heart failure at home.

Contact Information

Website
www.endotronix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1415 West Diehl Road
  • Suite 500W
  • Naperville, IL 60563
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Acquirer
Edwards Lifesciences
Vertical(s)
Digital Health, SaaS, HealthTech
Corporate Office
  • 1415 West Diehl Road
  • Suite 500W
  • Naperville, IL 60563
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endotronix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 19-Aug-2024 $600M Completed Generating Revenue
14. Debt - PPP 11-Apr-2020 Completed Generating Revenue
13. Later Stage VC (Series D) 24-Sep-2019 Completed Generating Revenue
12. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
11. Later Stage VC (Series C) 12-Feb-2018 Completed Generating Revenue
10. Later Stage VC (Series AA) 06-Nov-2017 Completed Generating Revenue
9. Debt - General 09-Jan-2017 Completed Generating Revenue
8. Later Stage VC (Series B) 29-Apr-2014 Completed Generating Revenue
7. Angel (individual) 01-May-2013 $1.5M $8.36M Completed Generating Revenue
6. Angel (individual) 01-May-2012 $1.8M $6.86M Completed Generating Revenue
To view Endotronix’s complete valuation and funding history, request access »

Endotronix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series D Voting
Series C Voting
Series C
Series B 17,631,414 $0.000010 5% $0.58 $0.58 1x $0.58 5.2%
Series A 7,707,622 $0.000010 5% $0.52 $0.52 1x $0.52 2.28%
To view Endotronix’s complete cap table history, request access »

Endotronix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of proactive heart management tools designed to detect cardiac failure. The company's tools offer a patient ma
Enterprise Systems (Healthcare)
Naperville, IL
150 As of 2026

Boston, MA
 

Dallas, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endotronix Competitors (10)

One of Endotronix’s 10 competitors is Wellframe, a Private Equity-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wellframe Private Equity-Backed Boston, MA
Lightbeam Health Solutions Venture Capital-Backed Dallas, TX
Cooey Health Venture Capital-Backed Sunnyvale, CA
eCaring Formerly VC-backed Woburn, MA
Norm. Venture Capital-Backed Dublin, Ireland
You’re viewing 5 of 10 competitors. Get the full list »

Endotronix Patents

  • 355

    Total Documents Applications and Grants

  • Total Patents Families

  • 182

    Granted

  • 46

    Pending

  • Expiring in next 12 mo

Endotronix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024276539-A1 Wireless sensor reader with multiple fixed excitation frequencies Pending 23-May-2023
EP-4716496-A2 Wireless sensor reader with multiple fixed excitation frequencies Pending 23-May-2023
JP-2026522216-A Wireless sensor reader with multiple fixed excitation frequencies Pending 23-May-2023
US-20260076571-A1 Wireless sensor reader with multiple fixed excitation frequencies Pending 23-May-2023
WO-2024243404-A2 Wireless sensor reader with multiple fixed excitation frequencies Inactive 23-May-2023 H04Q9/00
To view Endotronix’s complete patent history, request access »

Endotronix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endotronix Former Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aperture Venture Partners Venture Capital Minority
BV Capital Partners PE/Buyout Minority
BioVentures Investors Venture Capital Minority
Central Illinois Angels Angel Group Minority
Cornerstone Angels Angel Group Minority
You’re viewing 5 of 21 investors. Get the full list »

Endotronix Acquisitions (1)

Endotronix’s most recent deal was a Merger/Acquisition with Vital Sensors. The deal was made on 01-May-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vital Sensors 01-May-2020 Merger/Acquisition Monitoring Equipment
To view Endotronix’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Endotronix FAQs

  • When was Endotronix founded?

    Endotronix was founded in 2007.

  • Where is Endotronix headquartered?

    Endotronix is headquartered in Naperville, IL.

  • What is the size of Endotronix?

    Endotronix has 150 total employees.

  • What industry is Endotronix in?

    Endotronix’s primary industry is Enterprise Systems (Healthcare).

  • Is Endotronix a private or public company?

    Endotronix is a Private company.

  • What is the current valuation of Endotronix?

    The current valuation of Endotronix is .

  • What is Endotronix’s current revenue?

    The current revenue for Endotronix is .

  • How much funding has Endotronix raised over time?

    Endotronix has raised $141M.

  • Who are Endotronix’s investors?

    Aperture Venture Partners, BV Capital Partners, BioVentures Investors, Central Illinois Angels, and Cornerstone Angels are 5 of 21 investors who have invested in Endotronix.

  • Who are Endotronix’s competitors?

    Wellframe, Lightbeam Health Solutions, Cooey Health, eCaring, and Norm. are some of the 10 competitors of Endotronix.

  • When was Endotronix acquired?

    Endotronix was acquired on 19-Aug-2024.

  • Who acquired Endotronix?

    Endotronix was acquired by Edwards Lifesciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process